Director/PDMR Shareholding

RNS Number : 2182C

Dechra Pharmaceuticals PLC

02 March 2011

 



Dechra Pharmaceuticals PLC 

("the Company")

 Directors / PDMR Share Dealing

2 March 2011

Dechra Pharmaceuticals PLC announces the following:

Exercise of LTIP options:

On 1 March 2011, the following Directors exercised options over ordinary shares of 1p each in the Company, granted to them on 29 February 2008 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP).  Each participant paid an exercise price of £1: 

Name	Capacity	Options Exercised	Shares Sold	Sale Price per share	Total beneficial shareholding following this announcement	Percentage of issued share capital
Ian Page	Director	37,975	19,426	£5.0775	726,282	1.096%
Simon Evans	Director	22,152	0	0	882,689	1.332%
Edwin Torr	Director	20,253	10,361	£5.0775	411,381	0.621%

The exercise of the LTIP options were subject to the achievement of performance conditions which were satisfied in full.

All Directors (other than Simon Evans) have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

For further information

Zoe Goulding, Company Secretary            

Telephone number: 01782 771100

 

END

 

 

RDSDKBDPPBKDDNK